You need to enable JavaScript to run this app.
Recon: Novo reports heart benefit for weight-loss drug Wegovy; Emergent to lay off 400 staff
Recon
Jason Scott
Biologics/ biosimilars/ vaccines
Diagnostics/IVDs
Europe
Global
Medical Devices
North America
Pharmaceuticals
Regulatory Intelligence/Policy